LigaSure RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated
Covidien LLC · Decision date Sep 15, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on 2026-09-15 for K261070, a traditional 510(k) submitted by Covidien, LLC of Lafayette, Colorado, and received on 04/01/2026. The device is the LigaSure™ RAS Maryland Jaw Vessel Sealer/Divider, Nano-coated, listed under the classification name Electrosurgical, Cutting & Coagulation & Accessories, regulation 878.4400, with primary product code GEI and subsequent product code SCV. The review panel and regulation medical specialty were General & Plastic Surgery.
SESE denotes 510(k) clearance rather than PMA approval. The record shows no third-party review, no combination product status and no authorized predetermined change control plan. The summary document is linked but its contents were not captured here, so the specific component or modification distinguishing this device from its predicate, and any indications for use, remain unknown. The subsequent product code SCV is listed without explanation in the source.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Sep 15, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261070
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Covidien LLC
- Product code
- GEI
- Decision code
- SESE
- Decision date
- Sep 15, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Electrosurgical, Cutting & Coagulation & Accessories.
- Applicant
- Covidien LLC
- Product code
- GEI
- FDA device class
- 2
FDA decision timeline
K261070 received
Application receipt date recorded by FDA.
K261070 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code GEI
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Single Pass, Inc. | 510(k) clearance | Oct 26, 2026 | FDA | |
| Stryker Instruments | 510(k) clearance | Oct 20, 2026 | FDA | |
| Ethicon Endo-Surgery, LLC | 510(k) clearance | Sep 17, 2026 | FDA | |
| Stryker Instruments | 510(k) clearance | Sep 17, 2026 | FDA | |
Potenza PrimeK254185 | Jeisys Medical Incorporated | 510(k) clearance | Sep 11, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Covidien LLC
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Lafayette, CO
Sources and methodology
- Original FDA record: K261070
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


